Literature DB >> 32541980

[Relationship between serum vitamin E concentration in first trimester and the risk of developing hypertension disorders complicating pregnancy].

W Y Meng1, W T Huang2, J Zhang2, M Y Jiao3, L Jin2, L Jin2.   

Abstract

OBJECTIVE: To investigate the incidence of hypertension disorders complicating pregnancy (HDCP) and vitamin E (VE) nutritional status among pregnant women in Beijing, and to determine the relationship between serum VE concentration in the first trimester of pregnancy and the risk of developing HDCP.
METHODS: A retrospective cohort study was performed including 22 283 cases of pregnant women who underwent singleton deliveries in Tongzhou Maternal & Child Health Hospital of Beijing from January 2016 through December 2018 and received tests of serum VE concentrations in the first trimester of pregnancy. Nonconditional Logistic regression model was used to analyze the association between serum VE concentration levels and the risk of developing HDCP.
RESULTS: The total incidence of HDCP was 5.4%, with the incidence of gestational hypertension around 2.1% and the incidence of preeclampsia-eclampsia around 3.3%. The median concentration of serum VE in early pregnancy was 10.1 (8.8-11.6) mg/L, and 99.7% of the participants had normal serum VE concentrations. The incidence of gestational hypertension and that of preeclampsia-eclampsia had been annually increasing in three years; a linear-by-linear association had also been observed between the serum VE concentrations and the years of delivery. According to the results of the univariable and the multivariable Logistic regression analyses, higher risks of developing HDCP had been observed among women with higher serum VE concentrations. Compared to those with serum VE concentrations in interquartile range (P25-P75) of all the participants, the women whose serum VE concentrations above P75 were at higher risks to be attacked by HDCP (OR = 1.34, P < 0.001), gestational hypertension (OR = 1.39, P = 0.002), or preeclampsia-eclampsia (OR = 1.34, P = 0.001), as suggested by the results of the multivariable Logistic regression model analyses. In addition, the women with serum VE concentrations of 11.2 mg/L or above had a significantly higher risk of developing HDCP than those whose serum VE concentrations of P40-P60 of all the participants, and this risk grew higher as serum VE concentrations in the first trimester of pregnancy increased.
CONCLUSION: Women in Beijing are at good nutritional status. From January 2016 to December 2018, the incidence of HDCP increased with serum VE concentration level, and serum VE concentration of 11.2 mg/L is an indicator of an increased risk of developing HDCP, suggesting that pregnant women should take nutritional supplements containing VE carefully.

Entities:  

Keywords:  Cohort study; Eclampsia; Hypertension; Pregnancy; Vitamin E

Mesh:

Substances:

Year:  2020        PMID: 32541980      PMCID: PMC7433425          DOI: 10.19723/j.issn.1671-167X.2020.03.012

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  15 in total

Review 1.  Latest advances in understanding preeclampsia.

Authors:  Christopher W Redman; Ian L Sargent
Journal:  Science       Date:  2005-06-10       Impact factor: 47.728

2.  Clinical risk factors for preeclampsia in the 21st century.

Authors:  Emmanuelle Paré; Samuel Parry; Thomas F McElrath; Dominick Pucci; Amy Newton; Kee-Hak Lim
Journal:  Obstet Gynecol       Date:  2014-10       Impact factor: 7.661

3.  Vitamins C and E and the risks of preeclampsia and perinatal complications.

Authors:  Alice R Rumbold; Caroline A Crowther; Ross R Haslam; Gustaaf A Dekker; Jeffrey S Robinson
Journal:  N Engl J Med       Date:  2006-04-27       Impact factor: 91.245

4.  Dietary consumption and plasma concentrations of vitamin E in pregnancies complicated by preeclampsia.

Authors:  E Schiff; S A Friedman; M Stampfer; L Kao; P H Barrett; B M Sibai
Journal:  Am J Obstet Gynecol       Date:  1996-10       Impact factor: 8.661

5.  HPLC method for simultaneous determination of retinol, alpha-tocopherol and coenzyme Q10 in human plasma.

Authors:  Joanna Karpińska; Bozena Mikołuć; Radosław Motkowski; Janina Piotrowska-Jastrzebska
Journal:  J Pharm Biomed Anal       Date:  2006-06-09       Impact factor: 3.935

6.  Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial.

Authors:  L Poston; A L Briley; P T Seed; F J Kelly; A H Shennan
Journal:  Lancet       Date:  2006-04-08       Impact factor: 79.321

7.  A prospective study of pregnancy outcome and biomarkers of oxidative stress in nulliparous obese women.

Authors:  Daghni Rajasingam; Paul T Seed; Annette L Briley; Andrew H Shennan; Lucilla Poston
Journal:  Am J Obstet Gynecol       Date:  2009-02-06       Impact factor: 8.661

Review 8.  Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis.

Authors:  Mitsumasa Umesawa; Gen Kobashi
Journal:  Hypertens Res       Date:  2016-09-29       Impact factor: 3.872

9.  The 2011 survey on hypertensive disorders of pregnancy (HDP) in China: prevalence, risk factors, complications, pregnancy and perinatal outcomes.

Authors:  Chun Ye; Yan Ruan; Liying Zou; Guanghui Li; Changdong Li; Yi Chen; Chaoxia Jia; Ian L Megson; Jun Wei; Weiyuan Zhang
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

Review 10.  Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies.

Authors:  Emily Bartsch; Karyn E Medcalf; Alison L Park; Joel G Ray
Journal:  BMJ       Date:  2016-04-19
View more
  3 in total

1.  Correlation of serum vitamin A and vitamin E levels with the occurrence and severity of preeclampsia.

Authors:  Sijing Duan; Yong Jiang; Kai Mou; Yi Wang; Shanshan Zhou; Bingxin Sun
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  [Relationship between micronutrients supplementation during periconceptional period and serum concentration of vitamin E in the 1st trimester of gestational period].

Authors:  Y F Xing; C Y Liu; W Y Meng; J Zhang; M Y Jiao; L Jin; L Jin
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-06-18

3.  A Multi-Objective Approach for Drug Repurposing in Preeclampsia.

Authors:  Eduardo Tejera; Yunierkis Pérez-Castillo; Andrea Chamorro; Alejandro Cabrera-Andrade; Maria Eugenia Sanchez
Journal:  Molecules       Date:  2021-02-03       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.